Genomic Medicine Program Advisory Committee; Notice of Meeting, 54120 [E9-25367]

Download as PDF 54120 ACTION: Federal Register / Vol. 74, No. 202 / Wednesday, October 21, 2009 / Notices Notice. SUMMARY: The Treasury Department’s Office of Foreign Assets Control (‘‘OFAC’’) is publishing the names of three individuals whose property and interests in property have been blocked pursuant to the Foreign Narcotics Kingpin Designation Act (‘‘Kingpin Act’’) (21 U.S.C. 1901–1908, 8 U.S.C. 1182). DATES: The designation by the Director of OFAC of the three individuals identified in this notice pursuant to section 805(b) of the Kingpin Act is effective on October 14, 2009. FOR FURTHER INFORMATION CONTACT: Assistant Director, Compliance Outreach & Implementation, Office of Foreign Assets Control, Department of the Treasury, Washington, DC 20220, tel: (202) 622–2490. SUPPLEMENTARY INFORMATION: Electronic and Facsimile Availability This document and additional information concerning OFAC are available on OFAC’s Web site (https:// www.treas.gov/ofac) or via facsimile through a 24-hour fax-on demand service, tel.: (202) 622–0077. jlentini on DSKJ8SOYB1PROD with NOTICES Background The Kingpin Act became law on December 3, 1999. The Kingpin Act establishes a program targeting the activities of significant foreign narcotics traffickers and their organizations on a worldwide basis. It provides a statutory framework for the President to impose sanctions against significant foreign narcotics traffickers and their organizations on a worldwide basis, with the objective of denying their businesses and agents access to the U.S. financial system and to the benefits of trade and transactions involving U.S. companies and individuals. The Kingpin Act blocks all property and interests in property, subject to U.S. jurisdiction, owned or controlled by significant foreign narcotics traffickers as identified by the President. In addition, the Secretary of the Treasury consults with the Attorney General, the Director of the Central Intelligence Agency, the Director of the Federal Bureau of Investigation, the Administrator of the Drug Enforcement Administration, the Secretary of Defense, the Secretary of State, and the Secretary of Homeland Security when designating and blocking the property and interests in property, subject to U.S. jurisdiction, of persons who are found to be: (1) Materially assisting in, or providing financial or technological support for or to, or providing goods or VerDate Nov<24>2008 17:33 Oct 20, 2009 Jkt 220001 services in support of, the international narcotics trafficking activities of a person designated pursuant to the Kingpin Act; (2) owned, controlled, or directed by, or acting for or on behalf of, a person designated pursuant to the Kingpin Act; or (3) playing a significant role in international narcotics trafficking. On October 14, 2009, OFAC designated three individuals whose property and interests in property are blocked pursuant to section 805(b) of the Kingpin Act. The list of additional designees is as follows: Individual 1. KARAYILAN, Murat; DOB 5 June 1954; alt. DOB 1950; POB Konak, Turkey; nationality Turkey; (individual) [SDNTK]. 2. ALTUN, Ali Riza; (a.k.a. ALTUG, Risa; a.k.a. KIVIRCIK, Ali; a.k.a. RIZA, Ebubekir); DOB 1 January 1956; POB Kucuk Sobecimen, Turkey; nationality Turkey; (individual) [SDNTK]. 3. AYDAR, Zubayir (a.k.a. AYDAR, Zubayin); DOB 1 Jan 1961; POB Yanikses, Turkey; nationality Turkey; (individual) [SDNTK]. Dated: October 14, 2009. Adam J. Szubin, Director, Office of Foreign Assets Control. [FR Doc. E9–25289 Filed 10–20–09; 8:45 am] BILLING CODE 4811–45–P oversight and protecting the privacy of Veterans. The meeting focus will include program updates, including a genetics education tool for health care providers and upcoming genomics research initiatives, as well as presentations on the Veterans’ survey results and clinical application of pharmacogenetics. Time will be allocated for receiving public comments at 3:30 p.m. Public comments will be limited to five minutes each. Individuals wishing to make oral statements before the Committee will be accommodated on a first-come, first-served basis. Individuals who speak are invited to submit 1–2 page summaries of their comments at the time of the meeting for inclusion in the official meeting record. The public may submit written statements for the Committee’s review to Dr. Sumitra Muralidhar, Designated Federal Officer, at Department of Veterans Affairs, Veterans Health Administration (121E), 810 Vermont Avenue, NW., Washington, DC 20420, or at sumitra.muralidhar@va.gov. Any member of the public wishing to attend the meeting or seeking additional information should contact Dr. Muralidhar at (202) 461–1669. Dated: October 15, 2009. By Direction of the Secretary. Vivian Drake, Acting Committee Management Officer. [FR Doc. E9–25367 Filed 10–20–09; 8:45 am] BILLING CODE P DEPARTMENT OF VETERANS AFFAIRS Genomic Medicine Program Advisory Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that the Genomic Medicine Program Advisory Committee will meet on November 10, 2009, at the Hamilton Crowne Plaza, 1001 14th Street NW., Washington, DC, from 8:30 a.m. to 5 p.m. The meeting is open to the public. The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care of Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans. The Committee will receive program updates including planned responses to recommendations, and will be asked to continue to provide insight into optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 DEPARTMENT OF VETERANS AFFAIRS Veterans’ Advisory Committee on Environmental Hazards; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Veterans’ Advisory Committee on Environmental Hazards will be held on November 9–10, 2009, at VA Central Office, 810 Vermont Avenue, NW., Washington, DC, from 8 a.m. to 4:30 p.m. each day. The sessions will be held in Room 630 on November 9 and Room C–7 on November 10. The meeting is open to the public. The purpose of the Committee is to provide advice to the Secretary of Veterans Affairs on adverse health effects that may be associated with exposure to ionizing radiation, and to make recommendations on proposed standards and guidelines regarding VA benefit claims based upon exposure to ionizing radiation. E:\FR\FM\21OCN1.SGM 21OCN1

Agencies

[Federal Register Volume 74, Number 202 (Wednesday, October 21, 2009)]
[Notices]
[Page 54120]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25367]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that the Genomic Medicine 
Program Advisory Committee will meet on November 10, 2009, at the 
Hamilton Crowne Plaza, 1001 14th Street NW., Washington, DC, from 8:30 
a.m. to 5 p.m. The meeting is open to the public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care of Veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    The Committee will receive program updates including planned 
responses to recommendations, and will be asked to continue to provide 
insight into optimal ways for VA to incorporate genomic information 
into its health care program while applying appropriate ethical 
oversight and protecting the privacy of Veterans. The meeting focus 
will include program updates, including a genetics education tool for 
health care providers and upcoming genomics research initiatives, as 
well as presentations on the Veterans' survey results and clinical 
application of pharmacogenetics.
    Time will be allocated for receiving public comments at 3:30 p.m. 
Public comments will be limited to five minutes each. Individuals 
wishing to make oral statements before the Committee will be 
accommodated on a first-come, first-served basis. Individuals who speak 
are invited to submit 1-2 page summaries of their comments at the time 
of the meeting for inclusion in the official meeting record.
    The public may submit written statements for the Committee's review 
to Dr. Sumitra Muralidhar, Designated Federal Officer, at Department of 
Veterans Affairs, Veterans Health Administration (121E), 810 Vermont 
Avenue, NW., Washington, DC 20420, or at sumitra.muralidhar@va.gov. Any 
member of the public wishing to attend the meeting or seeking 
additional information should contact Dr. Muralidhar at (202) 461-1669.

    Dated: October 15, 2009.

    By Direction of the Secretary.
Vivian Drake,
Acting Committee Management Officer.
[FR Doc. E9-25367 Filed 10-20-09; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.